Male Infertility Treatment Market - Global Industry Analysis

Male Infertility Treatment Market: By Techniques (DNA Fragmentation, Oxidative Stress Analysis, Sperm Penetration, Microscopic Analysis, Sperm Agglutination, And Others): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends, And Forecast, 2020 – 2028

Published Date: 22-Jul-2021 Category: Pharmaceutical Report Format : PDF Pages: 123 Report Code: ZMR-951 Status : Published

The Global Male Infertility Treatment Market was accounted for USD 305.8 Million in 2020 and is expected to reach USD 420.9 Million by 2028, growing at a CAGR of around 4% between 2021 and 2028.

Description

Global Male Infertility Treatment Market Overview     

The Global Male Infertility Treatment Market accounted for USD 305.8 Million in 2020 and is expected to reach USD 420.9 Million by 2028, growing at a CAGR of around 4% between 2021 and 2028.    

The male infertility treatment market is boosted majorly by the rising occurrence of male infertility cases everywhere in the world. For instance, as per WHO, one in every four couples in developing nations is probably going to be impacted by infertility. Additionally, to the present, couples who aren't ready to bear a toddler fail to travel for the costly therapy options for fulfilling their needs which ends in the development of the male infertility treatment market.

Moreover, increasing age, torpid lifestyle, and different psychological & environmental effects are the explanations that are directly in charge of elevating the development of the male infertility treatment market. On the opposite hand, discontinuation of treatment and emotional shock is the major restrainers that directly impact the event of the male infertility treatment market.

COVID-19 Impact Analysis

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. The industry is responding to COVID-19 with immediate changes designed to ensure the uninterrupted production of necessary devices while keeping workers safe. The manufacturers and government are working together to understand the need, changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the impact of significant interventions of governments. Given the importance to all to the economic development of cities, countries, and regions, the broader impact of COVID-19 on the worldwide economy is enormous.

Growth Factors

Continuous progress R&D along with low-cost treatment in the healthcare industry is likely to open growth opportunities for the development male infertility treatment market over the forecast period. For instance, in June 2018, the BJU International study discovered that a combination of CC (clomiphene citrate) and AZ (anastrozole) therapy shows potential in male infertility treatment, thereby boosting the male infertility treatment market.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Technique Segment Analysis Preview   

Based on techniques, the global male infertility treatment market is divided into 5 types such as sperm agglutination, oxidative stress analysis, DNA fragmentation, microscopic analysis, sperm penetration, and others. DNA fragmentation ruled the male infertility treatment market. The development of this method is credited to its highest accurateness followed by others.

Regional Segment Analysis Preview   

Region-wise, North America was the dominating area in 2016 for male infertility treatment market in terms of income owing to the accessibility of computer-guided technologically advanced screening tests. Moreover, lifestyle-associated factors such as stress, smoking, and obesity have become very common in European nations and the U.S., boosting the male infertility treatment market. The male infertility treatment market has the huge growth avenues in emerging regions such as Latin America and Asia Pacific owing to the increased disposable income, public awareness, healthcare infrastructure, and government initiatives.

Key Market Players & Competitive Landscape

The key companies operating in the Male Infertility Treatment market include Pharmaceutical Co. Ltd, Intas Pharmaceuticals Ltd., Access Pharmaceuticals, Inc., Cordex Pharma, Inc., Pantarhei Bioscience B, Halotech DNA SL, Merck Serono, Andrology Solutions, and SCSA diagnostics. These players are set to bolster the growth of male infertility treatment market in the years to come.

The global Male Infertility Treatment Market is segmented as follows:

By Male Technique

  • DNA fragmentation
  • Oxidative stress analysis
  • Sperm penetration
  • Microscopic analysis
  • Sperm agglutination
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1: Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2: Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Technique
        • 2.1.1.2. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Male Infertility Treatment Market , 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3: COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4: Male Infertility Treatment Market – Technique Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Technique, 2020 & 2028
    • 4.2. DNA Fragmentation
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Oxidative stress analysis
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Sperm penetration
      • 4.4.1. Market Size and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Microscopic analysis
      • 4.5.1. Market Size and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Sperm agglutination
      • 4.6.1. Market Size and Forecast, By Region (USD Billion)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.7. Others
      • 4.7.1. Market Size and Forecast, By Region (USD Billion)
      • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5: Male Infertility Treatment Market – Region Segment Analysis
    • 5.1. Overview
      • 5.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 5.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 5.2. North America
      • 5.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 5.2.2. North America Market Revenue, By Technique, 2016 – 2028
      • 5.2.5. U.S.
        • 5.2.5.1. U.S. Market Revenue, By Technique, 2016 – 2028
      • 5.2.6. Canada
        • 5.2.6.1. Canada Market Revenue, By Technique, 2016 – 2028
      • 5.2.7. Mexico
        • 5.2.7.1. Mexico Market Revenue, By Technique, 2016 – 2028
    • 5.3. Europe
      • 5.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 5.3.2. Europe Market Revenue, By Technique, 2016 – 2028
      • 5.3.5. Germany
        • 5.3.5.1. Germany Market Revenue, By Technique, 2016 – 2028
      • 5.3.6. France
        • 5.3.6.1. France Market Revenue, By Technique, 2016 – 2028
      • 5.3.7. U.K.
        • 5.3.7.1. U.K. Market Revenue, By Technique, 2016 – 2028
      • 5.3.8. Italy
        • 5.3.8.1. Italy Market Revenue, By Technique, 2016 – 2028
      • 5.3.9. Spain
        • 5.3.9.1. Spain Market Revenue, By Technique, 2016 – 2028
      • 5.3.10. Rest of Europe
        • 5.3.10.1. Rest of Europe Market Revenue, By Technique, 2016 – 2028
    • 5.4. Asia Pacific
      • 5.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 5.4.2. Asia Pacific Market Revenue, By Technique, 2016 – 2028
      • 5.4.5. China
        • 5.4.5.1. China Market Revenue, By Technique, 2016 – 2028
      • 5.4.6. Japan
        • 5.4.6.1. Japan Market Revenue, By Technique, 2016 – 2028
      • 5.4.7. India
        • 5.4.7.1. India Market Revenue, By Technique, 2016 – 2028
      • 5.4.8. South Korea
        • 5.4.8.1. South Korea Market Revenue, By Technique, 2016 – 2028
      • 5.4.9. South-East Asia
        • 5.4.9.1. South-East Asia Market Revenue, By Technique, 2016 – 2028
      • 5.4.10. Rest of Asia Pacific
        • 5.4.10.1. Rest of Asia Pacific Market Revenue, By Technique, 2016 – 2028
    • 5.5. Latin America
      • 5.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 5.5.2. Latin America Market Revenue, By Technique, 2016 – 2028
      • 5.5.5. Brazil
        • 5.5.5.1. Brazil Market Revenue, By Technique, 2016 – 2028
      • 5.5.6. Argentina
        • 5.5.6.1. Argentina Market Revenue, By Technique, 2016 – 2028
      • 5.5.7. Rest of Latin America
        • 5.5.7.2. Rest of Latin America Market Revenue, By Technique, 2016 – 20285
    • 5.6. The Middle-East and Africa
      • 5.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 5.6.2. The Middle-East and Africa Market Revenue, By Technique, 2016 – 2028
      • 5.6.5. GCC Countries
        • 5.6.5.1. GCC Countries Market Revenue, By Technique, 2016 – 2028
      • 5.6.6. South Africa
        • 5.6.6.1. South Africa Market Revenue, By Technique, 2016 – 2028
      • 5.6.7. Rest of Middle-East Africa
        • 5.6.7.1. Rest of Middle-East Africa Market Revenue, By Technique, 2016 – 2028
  • Chapter No. 6: Male Infertility Treatment Market – Industry Analysis
    • 6.1. Introduction
    • 6.2. Market Drivers
      • 6.2.1. Driving Factor 1 Analysis
      • 6.2.2. Driving Factor 2 Analysis
    • 6.3. Market Restraints
      • 6.3.1. Restraining Factor Analysis
    • 6.4. Market Opportunities
      • 6.4.1. Market Opportunity Analysis
    • 6.5. Porter’s Five Forces Analysis
    • 6.6. PEST Analysis
    • 6.7. Regulatory Landscape
    • 6.8. Technology Landscape
    • 6.9. Regional Market Trends
      • 6.9.1. North America
      • 6.9.2. Europe
      • 6.9.3. Asia Pacific
      • 6.9.4. Latin America
      • 6.9.5. The Middle-East and Africa
    • 6.10. Pricing Analysis
    • 6.11. Value Chain Analysis
    • 6.12. Downstream Buyers
    • 6.13. Distributors/Traders List
  • Chapter No. 7: Competitive Landscape
    • 7.1. Company Market Share Analysis – 2019
      • 7.1.1. Global Male Infertility Treatment Market : Company Market Share, 2019
      • 7.1.2. Global Male Infertility Treatment Market , Company Market Revenue, 2016 – 2019 (USD Billion)
      • 7.1.3. Global Male Infertility Treatment Market , Company Y-o-Y Growth, 2017 – 2028 (%)
      • 7.1.4. Global Male Infertility Treatment Market : Radar Determinant Chart, 2019
    • 7.2. Strategic Developments
      • 7.2.1. Acquisitions & Mergers
      • 7.2.2. New Product Launch
      • 7.2.3. Regional Expansion
    • 7.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 8: Company Profiles
    • 8.1. ZydusCadila Healthcare Limited
      • 8.1.1. Company Overview
      • 8.1.2. Key Executives
      • 8.1.3. Product Portfolio
      • 8.1.4. Financial Overview
      • 8.1.5. Operating Business Segments
      • 8.1.6. Business Performance
      • 8.1.7. Recent Developments
    • 8.2. ASKA Pharmaceutical Co. Ltd
    • 8.3. Intas Pharmaceuticals Ltd.
    • 8.4. Access Pharmaceuticals, Inc.
    • 8.5. Cordex Pharma, Inc.
    • 8.6. Pantarhei Bioscience B
    • 8.7. Halotech DNA SL
    • 8.8. Merck Serono
    • 8.9. Andrulogy Sulutions
    • 8.10. SCSA diagnostics
  • Chapter No. 9: Marketing Strategy Analysis
    • 9.1. Marketing Channel
    • 9.2. Direct Marketing
    • 9.3. Indirect Marketing
    • 9.4. Marketing Channel Development Trends
    • 9.5. Economic/Pulitical Environmental Change
  • Chapter No. 10: Research Methodology
    • 10.1. Research Methodology
    • 10.2. Phase I - Secondary Research
    • 10.3. Phase II - Data Modeling
      • 10.3.1. Company Share Analysis Model
      • 10.3.2. Revenue Based Modeling
    • 10.4. Phase III - Primary Research
    • 10.5. Research Limitations
      • 10.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Technique
FIG NO. 2. Market Attractiveness Analysis, By Region
FIG NO. 3. Global Male Infertility Treatment Market  Revenue, 2016 – 2028 (USD Billion)
FIG NO. 4. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 5. Market Revenue Share, By Technique, 2020 & 2028
FIG NO. 6. Global Male Infertility Treatment Market  for DNA Fragmentation, Revenue (USD Billion) 2016 – 2028
FIG NO. 7. Comparative Revenue Analysis of Male Infertility Treatment Market  for DNA Fragmentation, By Country, 2020 & 2028
FIG NO. 8. Global Male Infertility Treatment Market  for Oxidative stress analysis, Revenue (USD Billion) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Male Infertility Treatment Market  for Oxidative stress analysis, By Country, 2020 & 2028
FIG NO. 10. Global Male Infertility Treatment Market  for Sperm penetration, Revenue (USD Billion) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Male Infertility Treatment Market  for Sperm penetration, By Country, 2020 & 2028
FIG NO. 12. Global Male Infertility Treatment Market  for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Male Infertility Treatment Market  for Others, By Country, 2020 & 2028
FIG NO. 14. Global Male Infertility Treatment Market  Revenue Share, By Region, 2020 & 2028
FIG NO. 15. North America Male Infertility Treatment Market  Revenue, 2016 - 2028 (USD Billion)
FIG NO. 16. Porter’s Five Forces Analysis for Global Male Infertility Treatment Market 
FIG NO. 17. PEST Analysis for Global Male Infertility Treatment Market 
FIG NO. 18. Pricing Analysis for Global Male Infertility Treatment Market 
FIG NO. 19. Value Chain Analysis for Global Male Infertility Treatment Market 
FIG NO. 20. Company Share Analysis, 2019
FIG NO. 21. Radar Determinant Chart, 2019
FIG NO. 22. Company Strategic Developments – Heat Map Analysis
FIG NO. 23. L-3 Security Detection Systems Business Segment Revenue Share, 2020 (%)
FIG NO. 24. L-3 Security Detection Systems Geographical Segment Revenue Share, 2020 (%)
FIG NO. 25. Market Channels
FIG NO. 26. Marketing Channel Development Trend
FIG NO. 27. Growth in World Gross Product, 2008-2018
FIG NO. 28. Research Methodology – Detailed View
FIG NO. 29. Research Methodology


Table Of Tables

List of Tables 

TABLE NO. 1. Global Male Infertility Treatment Market : Snapshot
TABLE NO. 2. Quarterly Male Infertility Treatment Market  Revenue by Region, 2020
TABLE NO. 3. Quarterly Male Infertility Treatment Market  Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
TABLE NO. 6. Global Male Infertility Treatment Market  for DNA Fragmentation, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Male Infertility Treatment Market  for Oxidative stress analysis, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Male Infertility Treatment Market  for Sperm penetration, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Male Infertility Treatment Market  for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Male Infertility Treatment Market  Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 11. North America Male Infertility Treatment Market  Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 12. North America Male Infertility Treatment Market  Revenue, By Technique, 2016 – 2028 (USD Billion)
TABLE NO. 13. U.S. Male Infertility Treatment Market  Revenue, By Technique, 2016 – 2028 (USD Billion)
TABLE NO. 14. Canada Male Infertility Treatment Market  Revenue, By Technique, 2016 – 2028 (USD Billion)
TABLE NO. 15. Mexico Male Infertility Treatment Market  Revenue, By Technique, 2016 – 2028 (USD Billion)
TABLE NO. 16. Drivers for the Male Infertility Treatment Market : Impact Analysis
TABLE NO. 17. Restraints for the Male Infertility Treatment Market : Impact Analysis
TABLE NO. 18. Major Buyers of Male Infertility Treatment
TABLE NO. 19. Distributors/Traders List of Male Infertility
TABLE NO. 20. Global Male Infertility Treatment Market , Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 21. Global Male Infertility Treatment Market , Company Y-o-Y Growth, 2017 – 2028 (USD Billion)

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Male Infertility Treatment Techniques market. Zion Research has collected and analyzed key data belong to the global Male Infertility Treatment Techniques market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Male Infertility Treatment Techniques across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Male Infertility Treatment Techniques industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases, and market reports

News articles, press releases, and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Male Infertility Treatment Techniques market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage, and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Reproduction is a simple and natural experience for most couples. However, for some cases, it becomes very difficult to conceive. Male infertility is a condition when the adult male is unable to make a fertile female pregnant after orgasm. It can occur due to low sperm count, the presence of less motile sperm, etc. Hypothalamus, pituitary gland and testis play a very important role in maintaining male fertility by controlling nerve signals and hormonal balance. The exact cause of male infertility is not known. But various causes associated with male infertility are smoking, excess alcohol consumption, obesity, stress, environmental toxins.

Globally, male infertility treatment market has been accelerated by increasing incidence of male infertility cases across the globe. Moreover, torpid lifestyle, increasing age, and environmental effects are the key factors responsible for increasing growth of male infertility market. However, due to emotional impact, discontinuation of treatment and social taboo are such limitations which directly affects the growth of male infertility treatment market. Nonetheless, medical tourism, awareness, low-cost treatment and ongoing research and development in healthcare sector technologies is expected to drive the growth avenues for the market over the years.

Global-Male-Infertility-Treatment-Market

Based on techniques, the global market for male infertility treatment is bifurcated into five types: DNA fragmentation, oxidative stress analysis, sperm penetration, microscopic analysis, sperm agglutination and others. DNA fragmentation accounted for the largest market share in terms of revenue and is also expected to have the highest CAGR during the forecast period. This is due to the accuracy level of the test. This test identifies the level of infertility by measuring the level of DNA damage.

Based on geographies, the global market for male infertility treatment market is bifurcated into five types: North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. These segments are further bifurcated into the U.S., UK, Germany, France, China, Japan, India, and Brazil. North America was the leading regional segments of male infertility treatment market in 2016, as in this region awareness, technology and affordability of drugs are high in number. Moreover, technological advancement and strong demand of diagnostic test would also account for market growth. The male infertility treatment market is expected to witness the highest growth in Asia-Pacific region after North America in upcoming years due to increase in technological advancement, awareness, excessive increase of health care infrastructure and growing percentage of infertility among males.

Key players of male infertility treatment market included in the report are ASKA Pharmaceutical Co. Ltd, Zydus Cadila Healthcare Limited, Access Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Pantarhei Bioscience B, Cordex Pharma, Inc., Merck Serono, Halotech DNA SL, SCSA diagnostics, Andrology Solutions.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global Male Infertility Treatment Market was valued at USD 305.8 million in 2020.

The global Male Infertility Treatment Market is expected to reach USD 420.9 million by 2028, growing at a CAGR of 4% between 2021 to 2028.

Some of the key factors driving the global Male Infertility Treatment Market growth are increasing age, torpid lifestyle, and different psychological & environmental effects are the reasons that are directly accountable for elevating development of male infertility treatment market.

North America region held a substantial share of the Male Infertility Treatment Market in 2020.

The key companies operating in Male Infertility Treatment market include ZydusCadila Healthcare Limited, ASKA Pharmaceutical Co. Ltd, Intas Pharmaceuticals Ltd., Access Pharmaceuticals, Inc., Cordex Pharma, Inc., Pantarhei Bioscience B, Halotech DNA SL, Merck Serono, Andrology Solutions, and SCSA diagnostics.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed